7si9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Emerging SARS-CoV-2 variants continue to threaten the effectiveness of COVID-19 vaccines, and small-molecule antivirals can provide an important therapeutic treatment option. The viral main protease (M(pro)) is critical for virus replication and thus is considered an attractive drug target. We performed the design and characterization of three covalent hybrid inhibitors BBH-1, BBH-2 and NBH-2 created by splicing components of hepatitis C protease inhibitors boceprevir and narlaprevir, and known SARS-CoV-1 protease inhibitors. A joint X-ray/neutron structure of the M(pro)/BBH-1 complex demonstrates that a Cys145 thiolate reaction with the inhibitor's keto-warhead creates a negatively charged oxyanion. Protonation states of the ionizable residues in the M(pro) active site adapt to the inhibitor, which appears to be an intrinsic property of M(pro). Structural comparisons of the hybrid inhibitors with PF-07321332 reveal unconventional F...O interactions of PF-07321332 with M(pro) which may explain its more favorable enthalpy of binding. BBH-1, BBH-2 and NBH-2 exhibit comparable antiviral properties in vitro relative to PF-07321332, making them good candidates for further design of improved antivirals. | |||
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease | Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease.,Kneller DW, Li H, Phillips G, Weiss KL, Zhang Q, Arnould MA, Jonsson CB, Surendranathan S, Parvathareddy J, Blakeley MP, Coates L, Louis JM, Bonnesen PV, Kovalevsky A Nat Commun. 2022 Apr 27;13(1):2268. doi: 10.1038/s41467-022-29915-z. PMID:35477935<ref>PMID:35477935</ref> | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
Revision as of 13:07, 4 May 2022
Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with PF-07321332
| ||||||||||||